Opus Genetics reports early positive data from gene therapy eye trial
Go back to Opus Genetics reports early positive data from gene therapy eye trial| Diversified Corporate Resources, Inc. (NASDAQ: IRD) | Delayed: 6.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.07 | 52 Week High | $0.02 | |||
| Open | $6.07 | 52 Week Low | $0.02 | |||
| Day High | $6.07 | P/E | N/A | |||
| Day Low | $6.07 | EPS | $0.00 | |||
| Volume | 10,418 | |||||
